Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Infectious Diseases of Poverty|May 26, 2020
Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017Rui-Hua Kang, Shu-Jia Liang, Yan-Ling Ma, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 13, 2012
[Study on the incidence of HIV and associated risk factors through a prospective cohort among men who have sex with men in Beijing, China]Dong-Liang Li, Yan-Jie Gao, Ming-Run Yu, et al.
BMJ Open|November 11, 2022
Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort studyLin Tang, Yanyang Zhang, Fuzhen Wang, et al.
Emerging Microbes & Infections|July 19, 2022
A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variantsDan Wu, Ying Ye, Lin Tang, et al.
Chinese Medical Journal|January 4, 2007
Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, ChinaJian-qing Xu, Jian-jun Wang, Li-feng Han, et al.
Diabetologia|December 2, 2024
Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function declineYuqing Chen, Federico Torta, Hiromi W L Koh, et al.
The Journal of Infectious Diseases|April 2, 2023
Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort StudyLin Tang, Fu-Zhen Wang, Lance E Rodewald, et al.
Chinese Medical Journal|November 30, 2020
Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT studyBin Su, Cheng Yao, Qing-Xia Zhao, et al.
Blood Cancer Discovery|October 18, 2021
Hyperthermia Selectively Destabilizes Oncogenic Fusion ProteinsYasen Maimaitiyiming, Qian Qian Wang, Chang Yang, et al.
Pageof 14